Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis

Heart, Artery and Coronary Diseases

The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y₁₂ Inhibitor in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Circulation.

O'Donoghue ML, Murphy SA, Sabatine MS

doi: 10.1161/CIRCULATIONAHA.120.046251.

Atrial FibrillationTherapy and Intervention

P2Y₁₂ inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis

Heart.

Lupercio F, Giancaterino S, Villablanca PA, Han F, Hoffmayer K, Ho G, Raissi F, Krummen D, Birgersdotter-Green U, Feld G, Reeves R, Mahmud E, Hsu JC

doi: 10.1136/heartjnl-2019-315963.

Cardiac Arrest or DeathAtrial FibrillationHeart, Artery and Coronary DiseasesThrombosis and StrokeTherapy and Intervention

Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials

Circulation

Trifan G, Gorelick PB, Testai FD

doi: 10.1161/CIRCULATIONAHA.121.053782

COMMENTED

Lipid-Lowering Drugs

Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants

Am Heart J.

Yebyo HG, Aschmann HE, Kaufmann M, Puhan MA

doi: 10.1016/j.ahj.2018.12.007.

Atrial FibrillationMyocardial InfarctionThrombosis and Stroke

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials

BMJ

Valgimigli M, Gragnano F, Branca M, Franzone A, Baber U, Jang Y, Kimura T, Hahn JY, Zhao Q, Windecker S, Gibson CM, Kim BK, Watanabe H, Song YB, Zhu Y, Vranckx P, Mehta S, Hong SJ, Ando K, Gwon HC, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Jüni P, Mehran R

doi: 10.1136/bmj.n1332

Heart, Artery and Coronary DiseasesHeart Failure

Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation: A Systematic Review and Meta-analysis

JAMA Cardiol.

Sannino A, Smith RL 2nd, Schiattarella GG, Trimarco B, Esposito G, Grayburn PA

doi: 10.1001/

Heart, Artery and Coronary DiseasesMyocardial InfarctionThrombosis and StrokeTherapy and Intervention

Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis

JAMA Cardiol.

Chiarito M, Cao D, Cannata F, Godino C, Lodigiani C, Ferrante G, Lopes RD, Alexander JH, Reimers B, Condorelli G, Stefanini GG

doi: 10.1001/

Heart, Artery and Coronary Diseases

Efficacy and Safety of High Potent P2Y12 Inhibitors Prasugrel and Ticagrelor in Patients With Coronary Heart Disease Treated With Dual Antiplatelet Therapy: A Sex-Specific Systematic Review and Meta-Analysis

J Am Heart Assoc.

Schreuder MM, Badal R, Boersma E, Kavousi M, Roos-Hesselink J, Versmissen J, Visser LE, Roeters van Lennep JE

doi: 10.1161/JAHA.119.014457.

Therapy and Intervention

P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials

Am Heart J.

Kuno T, Ueyama H, Takagi H, Bangalore S

doi: 10.1016/j.ahj.2020.06.008.

Related content

The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12 Inhibitor in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis